These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Experimental and clinical investigation on oxiconazole. Wu SX; Shen YN; Yan N; Guo NR; Liu LL; Yang JQ Chin Med J (Engl); 1989 Aug; 102(8):644-6. PubMed ID: 2517622 [TBL] [Abstract][Full Text] [Related]
24. [Experience with Variotin in clinics, polyclinics and medical practice in Europe]. Rieth H Mykosen; 1968 Jun; 11(6):471-4. PubMed ID: 4242214 [No Abstract] [Full Text] [Related]
25. Treatment of dermatomycoses with dibenzthione. Ziprkowski L Dermatol Int; 1965; 4(3):169-71. PubMed ID: 4226107 [No Abstract] [Full Text] [Related]
26. Tinea pedis in general practice. GOULD W; SCHWARTZ M Practitioner; 1956 Jun; 176(1056):670-3. PubMed ID: 13322802 [No Abstract] [Full Text] [Related]
27. [Treatment of the patients with epidermophytosis pedis]. Glukhen'kiĭ TT; Shugaĭlo VT; Iaremenko II Vrach Delo; 1967 Feb; 2():88-91. PubMed ID: 5617034 [No Abstract] [Full Text] [Related]
28. Haloprogin for tinea. Med Lett Drugs Ther; 1973 Aug; 15(17):69-70. PubMed ID: 4740517 [No Abstract] [Full Text] [Related]
29. Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic-type tinea pedis. Kikuchi I; Tanuma H; Morimoto K; Kawana S Mycoses; 2008 Nov; 51(6):523-31. PubMed ID: 18422915 [TBL] [Abstract][Full Text] [Related]
30. A case of bullous tinea pedis with dermatophytid reaction caused by Trichophyton violaceum. Romano C; Rubegni P; Ghilardi A; Fimiani M Mycoses; 2006 May; 49(3):249-50. PubMed ID: 16681820 [TBL] [Abstract][Full Text] [Related]
31. Diagnosis and management of common tinea infections. Noble SL; Forbes RC; Stamm PL Am Fam Physician; 1998 Jul; 58(1):163-74, 177-8. PubMed ID: 9672436 [TBL] [Abstract][Full Text] [Related]
32. The therapeutic effect of fatty acids and the antibiotic M-11 on tinea pedis. SCHERR GH; KORTH ZN; REYNOLD J; GOTHAM JE J Invest Dermatol; 1955 Nov; 25(5):335-40. PubMed ID: 13271840 [No Abstract] [Full Text] [Related]
33. Athlete's foot and fungally infected toenails. Authors should use familiar drug names. Melville A BMJ; 2001 May; 322(7297):1306-7. PubMed ID: 11403064 [No Abstract] [Full Text] [Related]
34. Clinical antifungal activity of thiabendazole. Battistini F; Zaias N; Sierra R; Rebell G Arch Dermatol; 1974 May; 109(5):695-9. PubMed ID: 4275184 [No Abstract] [Full Text] [Related]
35. Usefulness of 1% terbinafine HCl (Lamisil) cream for hyperkeratotic-type tinea pedis and its transfer into the horny layer. Tanuma H; Doi M; Ohta Y; Nishiyama S; Katsuoka K; Kaneko S; Mukai H; Abe M Mycoses; 2000; 43(11-12):417-32. PubMed ID: 11204359 [TBL] [Abstract][Full Text] [Related]
36. What defines the quality of patient care in tinea pedis? Mistik S; Ferahbas A; Koc AN; Ayangil D; Ozturk A J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):158-65. PubMed ID: 16441623 [TBL] [Abstract][Full Text] [Related]
37. I have athlete's foot. How should I treat it? Mayo Clin Health Lett; 2000 Jul; 18(7):8. PubMed ID: 10912397 [No Abstract] [Full Text] [Related]
38. Treatment of tinea pedis with a single pulse of itraconazole. Bonifaz A; Saúl A Eur J Dermatol; 2002; 12(2):157-9. PubMed ID: 11872413 [TBL] [Abstract][Full Text] [Related]